observational
    2012

    Silibinin as a treatment for Amanita phalloides poisoning: a systematic review of clinical experience

    Mengs U, Pohl RT, Mitchell T

    Published in Current Pharmaceutical Biotechnology

    Key Findings

    Intravenous silibinin given early was associated with low mortality in amatoxin poisoning across pooled clinical registries.

    Conclusions

    Strongest use case is the intravenous hepatoprotective indication.

    Limitations

    Registry data, no control group.

    Supplements Studied

    Early intravenous silibinin was associated with low mortality in amatoxin mushroom poisoning.

    Outcomes Measured

    Liver Protection

    Early intravenous silibinin was associated with low mortality in amatoxin poisoning.

    Study Details

    Year:2012
    Sample Size:1,500
    Quality Score:5/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.